Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Bunge (BG – Research Report), Commercial Metals Company (CMC – Research Report) and Chemours Company (CC – Research Report).
Bunge (BG)
In a report released today, Kenneth Zaslow from BMO Capital maintained a Buy rating on Bunge, with a price target of $108.00. The company’s shares closed last Tuesday at $87.78.
According to TipRanks.com, Zaslow is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Bunge with a $110.20 average price target.
See today’s best-performing stocks on TipRanks >>
Commercial Metals Company (CMC)
In a report released today, David Gagliano from BMO Capital maintained a Hold rating on Commercial Metals Company, with a price target of $34.00. The company’s shares closed last Tuesday at $32.45.
According to TipRanks.com, Gagliano is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Commercial Metals Company with a $36.00 average price target.
Chemours Company (CC)
In a report released today, John McNulty from BMO Capital maintained a Buy rating on Chemours Company, with a price target of $49.00. The company’s shares closed last Tuesday at $31.95.
According to TipRanks.com, McNulty is a 4-star analyst with an average return of
Chemours Company has an analyst consensus of Strong Buy, with a price target consensus of $48.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BG:
- Noble Financial Reaffirms Their Buy Rating on Seanergy Maritime (SHIP)
- With Sales Performance on a Roll, MongoDB Impresses Street
- Visa Launches Crypto Advisory Services
- Analysts Have Conflicting Sentiments on These Technology Companies: ON Semiconductor (ON), ams AG (OtherAUKUF) and Privia Health Group (PRVA)
- Analysts Offer Insights on Healthcare Companies: Omeros (OMER) and Recursion Pharmaceuticals (RXRX)
